The elderly are often hit hardest during flu season, and their vulnerability means that they tend to be targeted by vaccination programs. But is this always the best strategy?
Mar 14, 2014
0
0
Australia's federal Department of Health has advised general practitioners to be on the lookout for potential cases of the H7N9 strain of influenza A, or bird flu, following a spate of deaths in China.
Feb 10, 2014
0
0
The fall ritual of getting an annual influenza shot could join castor oil on the list of bygone remedies within a decade, some scientists say. And as that tradition fades away, so too will our fears of the virus mutating ...
Nov 21, 2013
0
0
Influenza is like a cloud, moving across Canada with the fall weather. McMaster researchers have established that the spread of seasonal flu in Canada is tied to low temperature and low humidity, and travels west to east—findings ...
Sep 11, 2013
1
0
Auckland medical scientists have helped to identify crucial risk factors for children most susceptible to life threatening infections from the H1N1 influenza virus.
Aug 14, 2013
0
0
With the use of sophisticated mathematical modelling techniques, a mathematician at PolyU and his co-researchers have completed a study that explains the phenomenon of multiple waves of influenza pandemic in the last century.
Jul 25, 2013
0
0
Three waves of the deadliest influenza pandemic in history, known as the Spanish flu, hit England and Wales in 1918, just as World War 1 was coming to an end.
Jul 9, 2013
0
0
Allowing all employees access to paid sick days would reduce influenza infections in the workplace, according to a first-of-its-kind analysis by University of Pittsburgh Graduate School of Public Health modeling experts.
Jun 13, 2013
0
0
Offering flu vaccines at elementary schools could expand vaccination rates and reduce costs, according to a new study reported in the scientific journal Vaccine by researchers from UC Davis Health System; the Monroe County, ...
Jun 5, 2013
0
0
Singapore's Agency for Science, Technology and Research (A*STAR) and Switzerland's Cytos Biotechnology AG today announced that the first healthy volunteer has been dosed in a Phase 1 clinical trial with their H1N1 influenza ...
May 17, 2013
1
0
